Deep01 - The First AI Medical Image solution provider obtained US & Taiwan FDA in Asia
FDA 510(K) No. K182875 (2019/07/10)
TFDA No. 006649 (2020/02/03)
Since DeepCT been development, the team has achieved several accomplishments.
DeepCT- The Tireless Force that Shorten Response Time and Sharpen Diagnosis
The ICH Notifier
According to studies, 40% of patients with ICH die in 1 month, and 75% of the survivors suffer from long-term neurological deficits.
That’s why early notification is the most important value of DeepCT. The development team works their efforts to work on this feature to shorten the time required to diagnose ICH. Thus patients will have a better chance to sustain their quality of life.